Ramsay Health Care (RHC) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of traditional custodians and welcome to shareholders both in-person and online.

• Board and executive team introduced, including new CEO Natalie Davis and new board member Craig Drummond.

• Chair and CEO addressed the meeting, emphasizing the core value of 'People caring for people' and clinical excellence.

• Procedures for questions and voting explained, with polling for all resolutions and results to be posted after the meeting.

Financial performance review

• Underlying net profit after tax from continuing operations rose 1.7% to AUD 305.3 million for FY25.

• Q1 Australia segment saw 6.5% total revenue growth and 5.8% EBIT growth year-on-year.

• Patient Net Promoter Score remained high at 72.6, with admissions up 2.6%.

• AUD 2.05 billion in funding facilities refinanced, reducing annual interest costs by ~$4m and improving loan margins by 30bps.

• Weighted average debt maturity extended to 3.3 years, with a 4.9% weighted average cost of debt.

Board and executive committee updates

• Smooth CEO transition to Natalie Davis, with new executive appointments in operations, commercial, technology, finance, strategy, and legal.

• Board renewal ongoing, with Craig Drummond joining and James McMurdo retiring.

• CEO priorities reaffirmed: transformation of the Australian hospital business, capital discipline, and cultural evolution.

• Board effectiveness review conducted, focusing on capability, board papers, and management investment.